MSB 2.70% 95.0¢ mesoblast limited

in vivo and in vitro are not used inappropriately in my view in...

  1. 2,799 Posts.
    lightbulb Created with Sketch. 1935
    in vivo and in vitro are not used inappropriately in my view in this post - reg's faith that the IL-2R potency assay wasn't used before though is clearly incorrect as any checking of the MSB submission to ODAC using the wayback machine can make clear - MSB has ALWAYS used both TNFR1 and Il2Ralpha.

    JB1975- I am asking questions JB, seeking input from any experts who follow these threads. I thought a different type of potency assay- still using IL2 - but different in some form or other- had been used but then changed to another .

    I don't mind being wrong- asking questions- seeking clarification etc.

    The query I have - of learned posters - is something from a IL2Ra assay has been presented that led to the FDA and the company changing their course.

    You have previously been dismissive of the assay - you are sticking to the same line- the main parties involved have overcome a stumbling block.

    Some-one, besides me, is missing something


    Silviu Itescu, Philip Krause, Eric Rose, Nicole Verdun, JB1975


    Veni Vidi Vici

    or

    Nero fiddles cum Roma ardet



    Well done to all Olympians- a special breed


    Reg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.